Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2024 Apr 20

PMID 38642176

Authors

Tianyi Zhang

Baoping Hu

Shilin Xu

Yuhe Wang

Hengxun Zhang

Xuemei Li

Xuguang Li

Tianbo Jin

Yongjun He

Affiliations

Soon will be listed here.

Abstract

In this cohort of 217 bladder cancer patients and 484 healthy controls, we explored the association between CYP24A1 variants (rs2762934, rs1570669, rs6068816, rs2296241) and bladder cancer risk in the Chinese Han population. Utilizing the Agena MassARRAY system, we genotyped four selected CYP24A1 polymorphisms. Logistic regression revealed a significant association of rs2762934 and rs1570669 with elevated bladder cancer risk, while rs6068816 exhibited a protective effect. Bioinformatics analysis of CYP24A1 expression in normal and cancerous bladder tissues indicated higher expression in normal tissue. In conclusion, our findings highlight the potential role of CYP24A1 variants in bladder cancer susceptibility.

References

Altunkol A, Savas M, Dilmec F, Utangac M, Abat D, Gumus K . Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method. Turk J Urol. 2018; 44(2):125-131. PMC: 5832373. DOI: 10.5152/tud.2018.23571. View

Anwar M, Ejaz M, Ijaz M, Ahmad G, Ayub H, Benish Ali S . Association of IL-17A promoter region SNP-rs2275913 with urinary bladder cancer. Int J Health Sci (Qassim). 2023; 17(3):33-38. PMC: 10155249. View

Bao Q, Wang D, Zhang Y, Bao L, Jia H . The Impact of CYP24A1 Polymorphisms on Hypertension Susceptibility. Kidney Blood Press Res. 2020; 45(1):28-37. DOI: 10.1159/000503925. View

Carlberg C, Velleuer E . Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2021; 196:114735. DOI: 10.1016/j.bcp.2021.114735. View

Chai L, Ni J, Ni X, Zhang N, Liu Y, Ji Z . Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population. PLoS One. 2021; 16(6):e0253474. PMC: 8244863. DOI: 10.1371/journal.pone.0253474. View

Dobruch J, Oszczudlowski M . Bladder Cancer: Current Challenges and Future Directions. Medicina (Kaunas). 2021; 57(8). PMC: 8402079. DOI: 10.3390/medicina57080749. View

Dunn J, Jefferson K, MacDonald D, Iqbal G, Bland R . Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism. J Steroid Biochem Mol Biol. 2019; 188:134-140. DOI: 10.1016/j.jsbmb.2019.01.002. View

Fuhrman B, Freedman D, Bhatti P, Doody M, Fu Y, Chang S . Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res. 2013; 33(2):543-51. PMC: 3866631. View

Javed M, Althwanay A, Ahsan F, Oliveri F, Goud H, Mehkari Z . Role of Vitamin D in Colorectal Cancer: A Holistic Approach and Review of the Clinical Utility. Cureus. 2020; 12(9):e10734. PMC: 7599058. DOI: 10.7759/cureus.10734. View

10.

Jiang X, Kiel D, Kraft P . The genetics of vitamin D. Bone. 2018; 126:59-77. DOI: 10.1016/j.bone.2018.10.006. View

11.

Li M, Li A, He R, Dang W, Liu X, Yang T . Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility. Cancer Med. 2019; 8(10):4892-4905. PMC: 6712450. DOI: 10.1002/cam4.2367. View

12.

Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka S . Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol. 2022; 5(6):628-639. DOI: 10.1016/j.euo.2022.10.003. View

13.

Munoz A, Grant W . Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022; 14(7). PMC: 9003337. DOI: 10.3390/nu14071448. View

14.

Pineda Lancheros L, Perez Ramirez C, Martin A, Galvez Navas J, Martinez Martinez F, Ramirez Tortosa M . Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer. Nutrients. 2021; 13(11). PMC: 8621267. DOI: 10.3390/nu13113783. View

15.

Purnomo A, Daryanto B, Seputra K, Budaya T, Lutfiana N, Nurkolis F . Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach. Cancers (Basel). 2023; 15(17). PMC: 10487222. DOI: 10.3390/cancers15174402. View

16.

Qian P, Cao X, Xu X, Duan M, Zhang Q, Huang G . Contribution of CYP24A1 variants in coronary heart disease among the Chinese population. Lipids Health Dis. 2020; 19(1):181. PMC: 7412795. DOI: 10.1186/s12944-020-01356-x. View

17.

Qu R, Li X, Quan X, Xia L, Fang X, Li H . Polymorphism in CYP24A1 Is Associated with Lung Cancer Risk: A Case-Control Study in Chinese Female Nonsmokers. DNA Cell Biol. 2019; 38(3):243-249. DOI: 10.1089/dna.2018.4510. View

18.

Qu W, Zhang F, Cheng Y, Li J, Zhou J . The impact of genetic variants in the gene on bladder cancer susceptibility. Front Endocrinol (Lausanne). 2022; 13:989030. PMC: 9554954. DOI: 10.3389/fendo.2022.989030. View

19.

Richters A, Aben K, Kiemeney L . The global burden of urinary bladder cancer: an update. World J Urol. 2019; 38(8):1895-1904. PMC: 7363726. DOI: 10.1007/s00345-019-02984-4. View

20.

Sadeghi H, Nazemalhosseini-Mojarad E, Piltan S, Fazeli E, Moradi Y, Amin-Beidokhti M . A candidate intronic gene variant affects the risk of colorectal cancer. Biomark Med. 2019; 14(1):23-29. DOI: 10.2217/bmm-2019-0189. View